U.S. Infectious Disease Diagnostics Markets

SUMMARY

Market Overview

The U.S. infectious disease diagnostics market will play a significant role in the dynamic IVD market. This market is segmented according to molecular, immunoassays, and culture infectious disease products. Total market revenues for base year 2005 are $3,823.1 with a CAGR of 7.7%. The most substantial growth is expected in the molecular segment. The U.S. infectious disease diagnostics market is highly competitive and saturated

Tremendous growth opportunities exist in the U.S. infectious disease in-vitro diagnostics market. High growth areas include viral load testing, nosocomial infection screening, rapid influenza detection, and STD testing.

Rapid detection and fast turn-around time (TAT) are able to lower total overall healthcare costs. Quick TAT is especially relevant to infectious disease testing, as fast diagnosis increases treatment options and patient prognosis.

Technical superiority of molecular methods is phasing out other types or more traditional methods, such as culture based tests, which have TATs of only days and are labor intensive.

TABLE OF CONTENTS

• 1. Executive Summary
  • 1. Executive Summary
    • 1. Executive Summary
• 2. Total Infectious Disease Diagnostics Market
  • 1. Market Overview
    • 1. Introduction
    • 2. Research Methodology
    • 3. Market Engineering Analysis
  • 2. Market Forecasts and Market Share Analysis
    • 1. Scope and Segmentation
    • 2. Market and Technology Trends
    • 3. Market Forecasts
    • 4. Market Share Analysis
  • 3. Market Challenges and Strategic Recommendations
    • 1. Industry Challenges
    • 2. Strategic Recommendations
• 3. Molecular Infectious Disease Diagnostics Market
  • 1. Market Overview and Forecasts
    • 1. Introduction
    • 2. Market Engineering Measurements
    • 3. Revenue Forecast
  • 2. Market Drivers and Restraints
    • 1. Market Drivers
    • 2. Market Restraints
  • 3. Competitive Analysis
    • 1. Competitive Structure
    • 2. Market Share Analysis
    • 3. Product Analysis
• 4. Immunoassay Infectious Disease Diagnostics Market
  • 1. Market Overview and Forecasts
    • 1. Introduction
    • 2. Market Engineering Measurements
    • 3. Revenue Forecast
  • 2. Market Drivers and Restraints
    • 1. Market Drivers
    • 2. Market Restraints
  • 3. Competitive Analysis
    • 1. Competitive Structure
    • 2. Market Share Analysis
    • 3. Product Analysis
• 5. Culture Infectious Disease Diagnostics Market
  • 1. Market Overview and Forecasts
    • 1. Introduction
    • 2. Market Engineering Measurements
    • 3. Revenue Forecast
  • 2. Market Drivers and Restraints
    • 1. Market Drivers
    • 2. Market Restraints
  • 3. Competitive Analysis
    • 1. Competitive Structure and Market Share Analysis
    • 2. Product Analysis
• 6. Appendix
  • 1. Decision Support Database
    • 1. Global Incidence of TB
    • 2. Global Reported AIDS Cases
    • 3. Global AIDS Mortality Rates
    • 4. Global Incidence of Haemophilus Type B
    • 5. Global Incidence of Hepatitis A
    • 6. Global Incidence of Hepatitis B
    • 7. Global HIV Prevalence
    • 8. Global Incidence of Malaria
    • 9. Global Cases of Rubella
    • 10. Global Incidence of Syphilis
    • 11. U.S. Initial Physician Visit for Genital Herpes
    • 12. U.S. Incidence of Haemophilus Influenzae
    • 13. U.S. Cases of Chlamydia
    • 14. U.S. Cases of Gonorrhea
    • 15. U.S. Cases of West Nile Virus

.